George Goldsmith, CEO at Compass Pathways, discusses show he developed a synthetic form of psilocybin, the psychoactive ingredient found in “magic mushrooms,” for use in treating depression. Goldsmith speaks with Bloomberg Businessweek anchor Carol Massar for the latest edition of Businessweek Talks.
Producer: Doni Holloway.

eToro CEO Yoni Assia Sees Bitcoin Returning to 'All Time High'
39:31

'Cats: The Jellicle Ball' Co-Directors Bill Rauch & Zhailon Levingston
12:06

Angi CEO Jeff Kip & Sally Beauty CEO Denise Paulonis on Earnings
27:59